BOLT Bolt Biotherapeutics, Inc.
Nasdaq · SEC CIK 1641281 · EDGAR
- Bought, last 12 months
- $5,594 4 purchases by 2 insiders
- Sold, last 12 months
- $128.3K 3 sales by 3 insiders
- Filings on record
- 95 since 2021-11-19, latest 2026-09-21 18:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Quinn William P. | Pres, CEO, CFO, Dir | $3,045 | $58.4K |
| Yonehiro Grant | COO | — | $43.8K |
| Nemec Sarah | Senior VP, Fin, PAO | $2,549 | $26.1K |
Transactions 24
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-21 18:05 | 2026-09-16+ | BOLT | Yonehiro Grant | COO | S - Sale | $3.32 | -13.2K | 17.3K | -43% | -$43.8K |
| 2026-09-21 18:04 | 2026-06-05 | BOLT | Nemec Sarah | Senior VP, Fin, PAO | P - Purchase | $3.88 | +509 | 1,924 | +36% | +$1,973 | |
| M | 2026-09-21 18:04 | 2026-09-16+ | BOLT | Nemec Sarah | Senior VP, Fin, PAO | S - Sale | $3.32 | -7,842 | 17.1K | -31% | -$26.1K |
| 2026-09-21 18:03 | 2026-06-05 | BOLT | Quinn William P. | Pres, CEO, CFO, Dir | P - Purchase | $3.88 | +637 | 2,950 | +28% | +$2,469 | |
| M | 2026-09-21 18:03 | 2026-09-16+ | BOLT | Quinn William P. | Pres, CEO, CFO, Dir | S - Sale | $3.32 | -17.6K | 25.4K | -41% | -$58.4K |
| D | 2026-02-04 | 2025-12-05 | BOLT | Quinn William P. | Pres, CEO, CFO, Dir | P - Purchase | $4.61 | +125 | 2,313 | +6% | +$576.25 |
| D | 2026-02-04 | 2025-12-05 | BOLT | Nemec Sarah | Senior VP, Fin, PAO | P - Purchase | $4.61 | +125 | 1,415 | +10% | +$576.25 |
| 2025-10-24 | 2025-10-22 | BOLT | Yonehiro Grant | COO | A - Grant | $0.00 | +30.0K | 38.9K | +336% | $0 | |
| 2025-10-24 | 2025-10-22 | BOLT | Nemec Sarah | Senior VP, Fin, PAO | A - Grant | $0.00 | +23.0K | 23.9K | +2,439% | $0 | |
| 2025-10-24 | 2025-06-06 | BOLT | Nemec Sarah | Senior VP, Fin, PAO | P - Purchase | $5.49 | +125 | 943 | +15% | +$686.25 | |
| 2025-10-24 | 2025-06-06 | BOLT | Quinn William P. | Pres, CEO, CFO, Dir | P - Purchase | $5.49 | +125 | 2,188 | +6% | +$686.25 | |
| 2025-10-24 | 2025-10-22 | BOLT | Quinn William P. | Pres, CEO, CFO, Dir | A - Grant | $0.00 | +40.0K | 42.2K | +1,828% | $0 | |
| DM | 2025-05-05 | 2024-06-06+ | BOLT | Quinn William P. | Pres, CEO, CFO, Dir | P - Purchase | $0.57 | +5,000 | 41.3K | +14% | +$2,850 |
| DM | 2025-05-05 | 2024-06-06+ | BOLT | Nemec Sarah | Senior VP, Fin, PAO | P - Purchase | $0.57 | +5,000 | 13.9K | +56% | +$2,850 |
| M | 2023-12-13 | 2023-06-06+ | BOLT | Quinn William P. | CFO | P - Purchase | $0.9496 | +11.8K | 26.3K | +82% | +$11.2K |
| MI | 2023-12-01 | 2023-11-29+ | BOLT | ENGLEMAN EDGAR | Dir | S - Sale | $0.8687 | -148.9K | 1.82M | -8% | -$129.3K |
| MI | 2023-11-22 | 2023-11-21 | BOLT | Vivo Capital VIII, LLC | 10% | S - Sale | $0.9 | -3,400 | 111.7K | -3% | -$3,060 |
| MI | 2023-11-22 | 2023-11-21 | BOLT | ENGLEMAN EDGAR | Dir | S - Sale | $0.9 | -1,943 | 1.95M | -0.1% | -$1,749 |
| MI | 2023-11-20 | 2023-11-16+ | BOLT | Vivo Capital Surplus Fund VIII, L.P. | 10% | S - Sale | $0.9289 | -86.1K | 1.98M | -4% | -$79.9K |
| MI | 2023-11-20 | 2023-11-16+ | BOLT | ENGLEMAN EDGAR | Dir | S - Sale | $0.9289 | -49.2K | 1.99M | -2% | -$45.7K |
| 2022-07-15 | 2022-07-13 | BOLT | Novo Holdings A/S | 10% | S - Sale | $2.00 | -800.0K | 3.70M | -18% | -$1.60M | |
| DM | 2022-02-01 | 2021-06-04+ | BOLT | Perez Edith A. | Chief Medical Off | P - Purchase | $12.93 | +1,328 | 1,328 | New | +$17.2K |
| D | 2022-02-01 | 2021-12-22 | BOLT | Perez Edith A. | Chief Medical Off | M - OptEx | $2.80 | +35.7K | 37.0K | +2,689% | +$100.0K |
| M | 2021-12-09 | 2021-06-04+ | BOLT | Quinn William P. | CFO | P - Purchase | $7.05 | +6,256 | 15.1K | +71% | +$44.1K |
Purchase Sale Sale after option exercise All abbreviations